Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Albemarle (GB:0HC7)
LSE:0HC7
Albemarle (0HC7) Share Price & Analysis
3 Followers
0HC7 Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$108.18 - $245.22
Previous Close$116.05
Volume3.15K
Average Volume (3M)7.46K
Market Cap
$13.44B
Enterprise Value$17.86B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$4.17B
Price to Earnings (P/E)8.7
Beta1.65
Next Earnings
May 01, 2024EPS Estimate
$0.25Next Dividend Ex-DateN/A
Dividend Yield1.4%
Share Statistics
EPS (TTM)13.34
Shares Outstanding117,402,949
10 Day Avg. Volume2,596
30 Day Avg. Volume7,460
Standard Deviation0.13
R-Squared0.43
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)1.88
Price to Sales (P/S)2.04
Price to Cash Flow (P/CF)-36.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.86
Enterprise Value/Gross Profit15.06
Enterprise Value/Ebitda21.80
Forecast
1Y Price Target
$144.32Price Target Upside24.36% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering20
Albemarle News
Bulls Say, Bears Say
Bulls Say
Financial StabilityAnalyst highlights that the recent capital increase positions Albemarle to expand and solidify its leadership without the need for additional equity raises.
Market ExpansionAnalyst indicates that growing lithium volumes and rising lithium prices contribute to a strong growth outlook for lithium miners.
Stock ValuationAnalyst updates the price target to USD160/share, with expectations for Albemarle's EBITDA to potentially triple by 2030, driven by increasing lithium demand.
Bears Say
Financial PerformanceValuation adjustments reflect higher interest expense with EPS estimates revised downwards and price target declining to reflect incremental debt.
Market DynamicsGuided 2024 scenarios, including low-end, well below consensus on declining lithium prices.
Stock DilutionIssuance of preferred equity results in approximately 16% dilution at the current stock price.
---
Options Prices
Currently, No data available
---
Ownership Overview
8.18% Insiders
34.27% Mutual Funds
28.56% Other Institutional Investors
29.00% Public Companies and
Individual Investors
0HC7 FAQ
What was Albemarle’s price range in the past 12 months?
Albemarle lowest share price was $108.17 and its highest was $245.22 in the past 12 months.
What is Albemarle’s market cap?
Currently, no data Available
When is Albemarle’s upcoming earnings report date?
Albemarle’s upcoming earnings report date is May 01, 2024 which is in 12 days.
How were Albemarle’s earnings last quarter?
Albemarle released its earnings results on Feb 14, 2024. The company reported $1.85 earnings per share for the quarter, beating the consensus estimate of $0.984 by $0.866.
Is Albemarle overvalued?
According to Wall Street analysts Albemarle’s price is currently Undervalued.
Does Albemarle pay dividends?
Albemarle does not currently pay dividends.
What is Albemarle’s EPS estimate?
Albemarle’s EPS estimate is $0.25.
How many shares outstanding does Albemarle have?
Albemarle has 117,524,680 shares outstanding.
What happened to Albemarle’s price movement after its last earnings report?
Albemarle reported an EPS of $1.85 in its last earnings report, beating expectations of $0.984. Following the earnings report the stock price went up 6.087%.
Which hedge fund is a major shareholder of Albemarle?
Among the largest hedge funds holding Albemarle’s share is PRIMECAP Management Co. It holds Albemarle’s shares valued at 502M.
---
Albemarle Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$144.32 (24.36% Upside)
$144.32 (24.36% Upside)
Blogger Sentiment
Bullish
GB:0HC7 Sentiment 90%
Sector Average 73%
Sector Average 73%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.88%
12-Months-Change
Fundamentals
Return on Equity
18.09%
Trailing 12-Months
Asset Growth
18.21%
Trailing 12-Months
Company Description
Albemarle
Albemarle Corp. is a specialty company, which engages in developing, manufacturing, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment engages in developing and manufacture of basic lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties and reagents. The Bromine Specialties segment consists of bromine and bromine-based business includes products used in fire safety solutions and other specialty chemicals applications. The Catalysts segment contain two product lines: clean fuels technologies, which is primarily composed of hydro processing catalysts, and heavy oil upgrading that comprises of fluidized catalytic cracking catalysts and additives. The company was founded in 1993 and is headquartered in Charlotte, NC.
---
0HC7 Company Deck
---
0HC7 Earnings Call
Q4 2024
0:00 / 0:00
---
0HC7 Stock 12 Months Forecast
Average Price Target
$144.32
▲(24.36% Upside)
Technical Analysis
Albemarle
―
Chemours Company
―
Sociedad Quimica Y Minera SA
―
FMC
―
Lithium Americas Corp.
―
Best Analysts Covering 0HC7
1 Year
1 Year Success Rate
15/37 ratings generated profit
1 Year Average Return
+15.28%
assigned a buy rating 2 months ago
Copying Colin Rusch's trades and holding each position for 1 Year would result in 40.54% of your transactions generating a profit, with an average return of +15.28% per trade.
---